Pheton Holdings Retained Earnings (Accumulated Deficit) 2025-2024 | PTHL
Pheton Holdings retained earnings (accumulated deficit) from 2025 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Pheton Holdings Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-1 |
| 2023 | $0 |
| 2022 | $0 |
| Pheton Holdings Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.027B | $0.000B |
| Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. | |||